[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fMDs_-Kbhub3tqc6DwN8tBXA8VNUzamTAkAdCSXMYw4Y":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":8,"totalEnrollment":9,"activePrograms":10,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":33,"phaseBuckets":39,"rows":46},"University of East Anglia",[4],78,false,5,6208,1,66,[13,16,19,22,24,27,29,31],{"name":14,"count":15},"Stroke",8,{"name":17,"count":18},"Asthma",6,{"name":20,"count":21},"Dementia",3,{"name":23,"count":21},"Sarcoidosis",{"name":25,"count":26},"Hip Fractures",2,{"name":28,"count":26},"Diabetes",{"name":30,"count":26},"Healthy",{"name":32,"count":26},"Idiopathic Pulmonary Fibrosis",[34],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT06715449","EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source","2026-07","Empagliflozin 10 MG",[40,41,42,43,44,45],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[47,83,120,147,174,226,244,270,296],{"intervention":38,"totalTrials":26,"cells":48},{"EARLY_PHASE1":49,"PHASE1":52,"PHASE2":54,"PHASE3":56,"PHASE4":79,"NA":81},{"trials":50,"activeCount":51},[],0,{"trials":53,"activeCount":51},[],{"trials":55,"activeCount":51},[],{"trials":57,"activeCount":10,"soonestReadout":37},[58,69],{"nctId":59,"briefTitle":60,"status":61,"phases":62,"primaryCompletion":63,"completion":63,"start":64,"enrollment":65,"conditions":66,"interventions":68},"NCT06469645","The Role of SGLT2i in Management of Moderate AS","UNKNOWN",[42,43],"2026-02","2024-05-30",104,[67],"Moderate Aortic Valve Stenosis",[38],{"nctId":35,"briefTitle":36,"status":70,"phases":71,"primaryCompletion":37,"completion":72,"start":73,"enrollment":74,"conditions":75,"interventions":78},"RECRUITING",[42,43],"2029-03","2024-11-22",100,[76,77],"Embolic Stroke of Undetermined Source","Atrial Fibrillation New Onset",[38],{"trials":80,"activeCount":51},[],{"trials":82,"activeCount":51},[],{"intervention":84,"totalTrials":26,"cells":85},"Montelukast",{"EARLY_PHASE1":86,"PHASE1":88,"PHASE2":90,"PHASE3":103,"PHASE4":105,"NA":118},{"trials":87,"activeCount":51},[],{"trials":89,"activeCount":51},[],{"trials":91,"activeCount":51},[92],{"nctId":93,"briefTitle":94,"status":95,"phases":96,"primaryCompletion":97,"completion":97,"start":98,"enrollment":99,"conditions":100,"interventions":101},"NCT00947453","Sputum Matrix Metalloproteinases (MMP) mRNA and Montelukast","COMPLETED",[42],"2011-12","2009-07",15,[17],[102],"montelukast",{"trials":104,"activeCount":51},[],{"trials":106,"activeCount":51},[107],{"nctId":108,"briefTitle":109,"status":95,"phases":110,"primaryCompletion":111,"completion":112,"start":113,"enrollment":114,"conditions":115,"interventions":117},"NCT01011452","Acute Montelukast in Asthma",[44],"2004-08","2004-10","2001-05",87,[116],"Acute Asthma Exacerbation",[84],{"trials":119,"activeCount":51},[],{"intervention":121,"totalTrials":10,"cells":122},"Simvastatin",{"EARLY_PHASE1":123,"PHASE1":125,"PHASE2":127,"PHASE3":129,"PHASE4":131,"NA":145},{"trials":124,"activeCount":51},[],{"trials":126,"activeCount":51},[],{"trials":128,"activeCount":51},[],{"trials":130,"activeCount":51},[],{"trials":132,"activeCount":51},[133],{"nctId":134,"briefTitle":135,"status":61,"phases":136,"primaryCompletion":137,"completion":138,"start":139,"enrollment":140,"conditions":141,"interventions":144},"NCT00680641","Simvastatin in Chronic Obstructive Pulmonary Disease (COPD)",[44],"2011-02","2012-02","2008-04",20,[142,143],"COPD","Emphysema",[121],{"trials":146,"activeCount":51},[],{"intervention":148,"totalTrials":10,"cells":149},"Teriparatide",{"EARLY_PHASE1":150,"PHASE1":152,"PHASE2":154,"PHASE3":156,"PHASE4":170,"NA":172},{"trials":151,"activeCount":51},[],{"trials":153,"activeCount":51},[],{"trials":155,"activeCount":51},[],{"trials":157,"activeCount":51},[158],{"nctId":159,"briefTitle":160,"status":61,"phases":161,"primaryCompletion":162,"completion":163,"start":164,"enrollment":165,"conditions":166,"interventions":169},"NCT04196855","Study of Teriparatide in Stress Fracture Healing",[43],"2022-06","2022-10","2019-12-23",136,[167,168],"Stress Fracture","Parathyroid Hormone",[148],{"trials":171,"activeCount":51},[],{"trials":173,"activeCount":51},[],{"intervention":175,"totalTrials":21,"cells":176},"Sodium Nitrite",{"EARLY_PHASE1":177,"PHASE1":179,"PHASE2":191,"PHASE3":220,"PHASE4":222,"NA":224},{"trials":178,"activeCount":51},[],{"trials":180,"activeCount":51},[181],{"nctId":182,"briefTitle":183,"status":61,"phases":184,"primaryCompletion":185,"completion":185,"start":186,"enrollment":187,"conditions":188,"interventions":190},"NCT03077763","The Haem and Nitrite Study - The Effects of Haemoglobin NO-blockade on Nitrite-induced Forearm Vessel Dilatation",[41],"2018-03","2016-12",41,[189],"Healthy Volunteers",[175],{"trials":192,"activeCount":51},[193,208],{"nctId":194,"briefTitle":195,"status":61,"phases":196,"primaryCompletion":197,"completion":197,"start":198,"enrollment":199,"conditions":200,"interventions":206},"NCT04001283","Nitrite Effects on Cardiac Muscle in CABG",[42],"2019-07-01","2013-01-21",75,[201,202,203,204,205],"Coronary Artery Disease","Atherosclerosis","Vascular Diseases","Cardiac Disease","Diabetes Mellitus",[175,207],"0.9% Sodium-chloride",{"nctId":209,"briefTitle":210,"status":95,"phases":211,"primaryCompletion":212,"completion":212,"start":213,"enrollment":214,"conditions":215,"interventions":219},"NCT04354051","The Nitrite and Coronary Flow Study",[41,42],"2018-12-01","2018-07-01",14,[216,217,218],"Cardiovascular Diseases","Vasodilation","Hypoxia",[175],{"trials":221,"activeCount":51},[],{"trials":223,"activeCount":51},[],{"trials":225,"activeCount":51},[],{"intervention":207,"totalTrials":10,"cells":227},{"EARLY_PHASE1":228,"PHASE1":230,"PHASE2":232,"PHASE3":238,"PHASE4":240,"NA":242},{"trials":229,"activeCount":51},[],{"trials":231,"activeCount":51},[],{"trials":233,"activeCount":51},[234],{"nctId":194,"briefTitle":195,"status":61,"phases":235,"primaryCompletion":197,"completion":197,"start":198,"enrollment":199,"conditions":236,"interventions":237},[42],[201,202,203,204,205],[175,207],{"trials":239,"activeCount":51},[],{"trials":241,"activeCount":51},[],{"trials":243,"activeCount":51},[],{"intervention":245,"totalTrials":10,"cells":246},"Theophylline",{"EARLY_PHASE1":247,"PHASE1":249,"PHASE2":251,"PHASE3":264,"PHASE4":266,"NA":268},{"trials":248,"activeCount":51},[],{"trials":250,"activeCount":51},[],{"trials":252,"activeCount":51},[253],{"nctId":254,"briefTitle":255,"status":95,"phases":256,"primaryCompletion":257,"completion":257,"start":258,"enrollment":259,"conditions":260,"interventions":263},"NCT01132781","Theophylline in Rhinitis",[42],"2012-06","2010-05",28,[261,17,262],"Rhinosinusitis","Allergic Rhinitis",[245],{"trials":265,"activeCount":51},[],{"trials":267,"activeCount":51},[],{"trials":269,"activeCount":51},[],{"intervention":271,"totalTrials":10,"cells":272},"Sodium Nitrate",{"EARLY_PHASE1":273,"PHASE1":275,"PHASE2":288,"PHASE3":290,"PHASE4":292,"NA":294},{"trials":274,"activeCount":51},[],{"trials":276,"activeCount":51},[277],{"nctId":278,"briefTitle":279,"status":61,"phases":280,"primaryCompletion":281,"completion":282,"start":283,"enrollment":284,"conditions":285,"interventions":287},"NCT03251287","Nitrite in Hypertrophic Cardiomyopathy (HCM) Study",[41],"2018-12","2019-01","2017-11",18,[286],"Cardiomyopathy, Hypertrophic",[271],{"trials":289,"activeCount":51},[],{"trials":291,"activeCount":51},[],{"trials":293,"activeCount":51},[],{"trials":295,"activeCount":51},[],{"intervention":297,"totalTrials":10,"cells":298},"Methylphenidate",{"EARLY_PHASE1":299,"PHASE1":301,"PHASE2":303,"PHASE3":305,"PHASE4":307,"NA":309},{"trials":300,"activeCount":51},[],{"trials":302,"activeCount":51},[],{"trials":304,"activeCount":51},[],{"trials":306,"activeCount":51},[],{"trials":308,"activeCount":51},[],{"trials":310,"activeCount":51},[311],{"nctId":312,"briefTitle":313,"status":61,"phases":314,"primaryCompletion":315,"completion":316,"start":317,"enrollment":318,"conditions":319,"interventions":321},"NCT02643732","Fatigue in Sarcoidosis - Treatment With Methylphenidate",[45],"2018-05","2018-07","2016-11",30,[23,320],"Fatigue",[297]]